Q4 2024 13F Holders as of 12/31/2024
-
Type / Class
-
Equity / Common Stock, $0.001 par value
-
Shares outstanding
-
55.5M
-
Number of holders
-
130
-
Total 13F shares, excl. options
-
34.6M
-
Shares change
-
-545K
-
Total reported value, excl. options
-
$196M
-
Value change
-
-$3.24M
-
Put/Call ratio
-
10.07
-
Number of buys
-
61
-
Number of sells
-
-54
-
Price
-
$5.67
Significant Holders of Voyager Therapeutics, Inc. - Common Stock, $0.001 par value (VYGR) as of Q4 2024
153 filings reported holding VYGR - Voyager Therapeutics, Inc. - Common Stock, $0.001 par value as of Q4 2024.
Voyager Therapeutics, Inc. - Common Stock, $0.001 par value (VYGR) has 130 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 34.6M shares
of 55.5M outstanding shares and own 62.32% of the company stock.
Largest 10 shareholders include ARMISTICE CAPITAL, LLC (5.4M shares), BlackRock, Inc. (5.36M shares), EcoR1 Capital, LLC (3.92M shares), VANGUARD GROUP INC (3.22M shares), FARALLON CAPITAL MANAGEMENT LLC (2.57M shares), DIMENSIONAL FUND ADVISORS LP (1.38M shares), Vestal Point Capital, LP (1.23M shares), GEODE CAPITAL MANAGEMENT, LLC (1.08M shares), Erste Asset Management GmbH (1.06M shares), and STATE STREET CORP (901K shares).
This table shows the top 130 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.